annual operating expenses:
$227.76M-$31.66M(-12.20%)Summary
- As of today (June 29, 2025), CPRX annual total operating expenses is $227.76 million, with the most recent change of -$31.66 million (-12.20%) on December 31, 2024.
- During the last 3 years, CPRX annual operating expenses has risen by +$161.20 million (+242.17%).
- CPRX annual operating expenses is now -12.20% below its all-time high of $259.43 million, reached on December 31, 2023.
Performance
CPRX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$60.14M+$2.81M(+4.90%)Summary
- As of today (June 29, 2025), CPRX quarterly total operating expenses is $60.14 million, with the most recent change of +$2.81 million (+4.90%) on March 31, 2025.
- Over the past year, CPRX quarterly operating expenses has increased by +$1.28 million (+2.17%).
- CPRX quarterly operating expenses is now -52.16% below its all-time high of $125.71 million, reached on September 30, 2023.
Performance
CPRX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CPRX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.2% | +2.2% |
| 3 y3 years | +242.2% | +203.3% |
| 5 y5 years | +308.7% | +321.0% |
CPRX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.2% | +242.2% | -52.2% | +255.8% |
| 5 y | 5-year | -12.2% | +308.7% | -52.2% | +337.9% |
| alltime | all time | -12.2% | >+9999.0% | -52.2% | >+9999.0% |
CPRX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $60.14M(+4.9%) |
| Dec 2024 | $227.76M(-12.2%) | $57.33M(-2.0%) |
| Sep 2024 | - | $58.51M(+10.3%) |
| Jun 2024 | - | $53.06M(-9.9%) |
| Mar 2024 | - | $58.86M(+10.9%) |
| Dec 2023 | $259.43M(+232.7%) | $53.07M(-57.8%) |
| Sep 2023 | - | $125.71M(+207.8%) |
| Jun 2023 | - | $40.84M(+2.6%) |
| Mar 2023 | - | $39.81M(+112.2%) |
| Dec 2022 | $77.97M(+17.1%) | $18.76M(-16.5%) |
| Sep 2022 | - | $22.48M(+33.0%) |
| Jun 2022 | - | $16.90M(-14.8%) |
| Mar 2022 | - | $19.83M(+8.9%) |
| Dec 2021 | $66.56M(+9.6%) | $18.22M(+9.5%) |
| Sep 2021 | - | $16.64M(+4.1%) |
| Jun 2021 | - | $15.98M(+1.6%) |
| Mar 2021 | - | $15.72M(-10.3%) |
| Dec 2020 | $60.73M(+9.0%) | $17.53M(+27.6%) |
| Sep 2020 | - | $13.73M(-9.5%) |
| Jun 2020 | - | $15.18M(+6.3%) |
| Mar 2020 | - | $14.29M(-19.4%) |
| Dec 2019 | $55.72M(+55.7%) | $17.72M(+39.9%) |
| Sep 2019 | - | $12.66M(-7.0%) |
| Jun 2019 | - | $13.62M(+16.1%) |
| Mar 2019 | - | $11.72M(-23.6%) |
| Dec 2018 | $35.80M(+91.6%) | $15.34M(+87.5%) |
| Sep 2018 | - | $8.18M(+29.1%) |
| Jun 2018 | - | $6.34M(+6.8%) |
| Mar 2018 | - | $5.93M(+7.6%) |
| Dec 2017 | $18.68M(-3.1%) | $5.51M(+28.0%) |
| Sep 2017 | - | $4.31M(+3.0%) |
| Jun 2017 | - | $4.18M(-10.7%) |
| Mar 2017 | - | $4.68M(+8.5%) |
| Dec 2016 | $19.28M(-5.5%) | $4.31M(+10.2%) |
| Sep 2016 | - | $3.91M(-18.7%) |
| Jun 2016 | - | $4.81M(-22.8%) |
| Mar 2016 | - | $6.24M(+0.7%) |
| Dec 2015 | $20.40M | $6.19M(+23.4%) |
| Sep 2015 | - | $5.02M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $4.90M(+14.1%) |
| Mar 2015 | - | $4.29M(+7.7%) |
| Dec 2014 | $14.59M(+41.5%) | $3.98M(-3.0%) |
| Sep 2014 | - | $4.11M(+37.4%) |
| Jun 2014 | - | $2.99M(-14.8%) |
| Mar 2014 | - | $3.51M(+29.6%) |
| Dec 2013 | $10.31M(+97.5%) | $2.71M(-16.6%) |
| Sep 2013 | - | $3.25M(+22.3%) |
| Jun 2013 | - | $2.65M(+55.6%) |
| Mar 2013 | - | $1.71M(+13.3%) |
| Dec 2012 | $5.22M(-14.2%) | $1.51M(+17.3%) |
| Sep 2012 | - | $1.28M(+20.3%) |
| Jun 2012 | - | $1.07M(-21.8%) |
| Mar 2012 | - | $1.36M(-32.9%) |
| Dec 2011 | $6.08M(+34.8%) | $2.03M(+79.9%) |
| Sep 2011 | - | $1.13M(-19.1%) |
| Jun 2011 | - | $1.40M(-8.0%) |
| Mar 2011 | - | $1.52M(+24.4%) |
| Dec 2010 | $4.51M(-38.0%) | $1.22M(+34.4%) |
| Sep 2010 | - | $908.50K(-31.9%) |
| Jun 2010 | - | $1.33M(+26.9%) |
| Mar 2010 | - | $1.05M(-10.2%) |
| Dec 2009 | $7.28M(-33.2%) | $1.17M(-9.5%) |
| Sep 2009 | - | $1.29M(-26.9%) |
| Jun 2009 | - | $1.77M(-41.9%) |
| Mar 2009 | - | $3.04M(-19.7%) |
| Dec 2008 | $10.89M(+116.7%) | $3.79M(+30.1%) |
| Sep 2008 | - | $2.91M(+18.3%) |
| Jun 2008 | - | $2.46M(+42.9%) |
| Mar 2008 | - | $1.72M(+50.9%) |
| Dec 2007 | $5.03M(+73.2%) | $1.14M(+20.2%) |
| Sep 2007 | - | $950.40K(-33.9%) |
| Jun 2007 | - | $1.44M(-4.0%) |
| Mar 2007 | - | $1.50M(+69.1%) |
| Dec 2006 | $2.90M(+59.3%) | $885.20K(-34.0%) |
| Sep 2006 | - | $1.34M(+276.0%) |
| Jun 2006 | - | $357.00K |
| Dec 2005 | $1.82M(+235.6%) | - |
| Dec 2004 | $543.00K(+112.2%) | - |
| Dec 2002 | $255.90K | - |
FAQ
- What is Catalyst Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual operating expenses year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly operating expenses year-on-year change?
What is Catalyst Pharmaceuticals annual total operating expenses?
The current annual operating expenses of CPRX is $227.76M
What is the all time high annual operating expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total operating expenses is $259.43M
What is Catalyst Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, CPRX annual total operating expenses has changed by -$31.66M (-12.20%)
What is Catalyst Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of CPRX is $60.14M
What is the all time high quarterly operating expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total operating expenses is $125.71M
What is Catalyst Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, CPRX quarterly total operating expenses has changed by +$1.28M (+2.17%)